顺势疗法市场分析及预测(按规模、份额、增长、趋势)2030

  • Report Code : TIPRE00007419
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 232
Buy Now

Homeopathy Market Size Report & Growth Outlook 2030

Buy Now

 

[研究报告] 顺势疗法市场预计将从 2022 年的 60.1614 亿美元增至 2030 年的 180.6991 亿美元。预计 2022 年至 2030 年期间,市场复合年增长率为 14.7%。

 

市场洞察和分析师观点:

顺势疗法是一种替代医学形式,它使用高度稀释的物质来刺激人体的自然治愈能力。有几个因素促成了顺势疗法市场的增长。慢性病和生活方式相关的健康问题的患病率一直在上升,顺势疗法常常被用来治疗慢性病和改善整体健康。人们对顺势疗法及其潜在益处的认识不断提高,以及医疗专业人士的接受度不断提高,促进了其更广泛的应用。顺势疗法产品主要来源于植物(如红洋葱、山金车 [山草]、毒藤、颠茄 [致命茄属植物] 和荨麻)、矿物质(如白砷)或动物(如压碎的整只蜜蜂)。顺势疗法产品通常制成糖丸放在舌下;它们也可以是其他形式,如软膏、凝胶、滴剂、乳霜和片剂。治疗方法是“个性化的”,也可以根据消费者的要求进行定制。

 

增长动力和挑战:

人们越来越担心对抗疗法药物或常规药物的潜在副作用。在亚洲和欧洲国家,消费者已经开始转向替代药物,例如自然疗法、顺势疗法和草药。一些熟练的顺势疗法医生也在宣传替代药物的益处,尤其是对患有心血管疾病和癌症等慢性疾病的患者。2017 年发表在《斯堪的纳维亚公共卫生杂志》上的一项研究表明,替代疗法主要以补充方式或与传统医学结合使用。例如,源自印度的传统药物姜黄(姜黄)是顺势疗法中必不可少的天然成分之一。这些传统或替代类型的药物在欧洲越来越受欢迎,这种趋势使发展中国家的天然成分供应商受益。

根据 Homeo Book 的数据,在过去的 30-40 年里,顺势疗法受益于大多数欧洲国家医生和消费者日益增长的需求。欧盟委员会的一项调查显示,四分之三的欧洲人知道顺势疗法,其中约 60% 的人在医疗保健中使用顺势疗法。在欧盟,超过 30,000 名医生参加了顺势疗法培训课程。此外,欧洲约 46-47% 的全科医生 (GP) 会不时开出没有接受过任何顺势疗法培训的顺势疗法药物,而 6-8% 的全科医生会更定期地开出这些药物。

长期以来,人们对口服药物和无副作用药物的偏好一直在上升,并且在未来几年将继续增长。对抗疗法含有强效药物;然而,它们并不适合所有人。此外,对抗疗法药物价格昂贵,对疾病只有短暂的效果。此外,尽管完成了处方药疗程,疾病仍可能复发。药物滥用的情况在对抗疗法药物中更为常见,这是转向天然药物的另一个因素。另一方面,顺势疗法药物价格低廉,没有或几乎没有副作用。因此,顺势疗法药物的日益普及促进了顺势疗法市场的增长。

 

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

顺势疗法市场:

顺势疗法市场
  • Homeopathy Market
    复合年增长率(2022 - 2030 年)
    14.7%
  • 2022 年市场规模
    60.2 亿美元
  • 2030 年市场规模
    180.7 亿美元

市场动态

增长动力
  • 顺势疗法产品的安全问题
  • 顺势疗法药物的采用率上升
未来的趋势
  • 植物性补充剂需求不断增长,创新顺势疗法药物不断推出
机会
  • 医疗支出和报销

关键人物;主力;重要一员

  •  
  • 福尔茨
  • 艾伦医疗有限公司
  • 哈尼曼实验室有限公司
  • Boiron, Homeocan Inc
  • Hyland's 公司
  • 纳尔逊药房有限公司
  • Weleda 英国
  • 生物医用产品 Heel GmbH
  • 安斯沃思(伦敦)有限公司

区域概况

Homeopathy Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Homeopathy Market来源
  • 植物
  • 动物
  • 矿物质
Homeopathy Market类型
  • 稀释
  • 酊剂
  •  生化
  • 软膏
  • 平板电脑
  • 其他的
Homeopathy Market应用
  • 镇痛解热
  • 呼吸系统
  • 神经病学
  • 免疫学
  • 胃肠病学
  • 皮肤科
  • 其他的
Homeopathy Market分销渠道
  • 顺势疗法诊所
  • 零售药店
  • 电子零售商
  • 其他的
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

报告细分和范围:

“全球顺势疗法市场”根据来源、类型、应用、分销渠道和地理位置进行细分。根据来源,顺势疗法市场分为植物、动物和矿物。植物部分在 2022 年占有最大份额。根据应用,全球顺势疗法市场细分为镇痛和解热、呼吸、神经病学、免疫学、胃肠病学、皮肤病学等。免疫学部分在 2022 年占有最大的市场份额,预计免疫学部分在预测期内将在市场上实现最高的复合年增长率。根据分销渠道,顺势疗法市场细分为顺势疗法诊所、零售药店、电子零售商和其他。顺势疗法诊所部分在 2022 年占有最大的市场份额,预计同一部分在预测期内将实现最高的复合年增长率。根据地理分布,全球顺势疗法市场分为北美(美国、加拿大和墨西哥)、欧洲(德国、法国、意大利、英国、俄罗斯和欧洲其他地区)、亚太地区(澳大利亚、中国、日本、印度、韩国和亚太其他地区)、中东和非洲(南非、沙特阿拉伯、阿联酋和中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)。

 

节段分析:

根据类型,顺势疗法市场细分为稀释剂、酊剂、生物化学品、软膏、​​片剂和其他。稀释剂部分在 2022 年占据了最大的市场份额。然而,软膏部分预计在预测期内将录得最高的复合年增长率 15.4%。顺势疗法药物是通过连续顺势疗法稀释的控制过程获得的。它们是通过粉碎植物、动物或矿物质来制备的。将提取物稀释在酒精和水的混合物中。不溶性固体通过与乳糖一起研磨来稀释。该过程重复数次以实现治疗稀释。每次稀释后,剧烈搅拌混合物;这个过程称为震荡。震荡过程确保了药物的治疗效果。人们对替代医疗实践效率的认识不断提高,尤其是在治疗慢性疾病方面,这是推动全球对顺势疗法稀释产品需求的关键因素。此外,由于人们对顺势疗法稀释剂功效的信任度不断提高,新兴国家的需求也在增长。此外,生活方式疾病的患病率不断上升,支持了顺势疗法稀释剂的顺势疗法市场的增长。

根据分销渠道,顺势疗法市场细分为顺势疗法诊所、零售药店、电子零售商等。顺势疗法诊所细分市场在 2022 年占据了最大的市场份额,预计同一细分市场在预测期内的复合年增长率最高,为 15.2%。由于成本考虑和个性化护理,患者逐渐从医院转向诊所,这可能会推动诊所细分市场的顺势疗法市场增长。此外,大量顺势疗法诊所的存在也有助于该细分市场的增长。例如,Star Homeopathy 在印度有 40 家分店。Dr Batra's 在印度 16 个城市拥有 63 家提供顺势疗法治疗的诊所。该诊所拥有 5 个国家的 10 家国际诊所。2019 年 4 月,它在阿布扎比开设了第一家诊所,以满足海湾地区对顺势疗法日益增长的需求。此外,2022 年 11 月,Namma 顺势疗法诊所因其有效的治疗服务而在马哈拉施特拉邦和卡纳塔克邦广受欢迎。这家顺势疗法诊所共有 20 家分店,遍布马哈拉施特拉邦和卡纳塔克邦,拥有 200 多名经验丰富且合格的医生,他们已成功治疗了 100,000 多种急性和慢性疾病。位于孟买达达尔的 Namma 顺势疗法诊所是亚洲最大的顺势疗法公司分店之一。

 

 

区域分析:

根据地理位置,顺势疗法市场分为五个主要区域:北美、欧洲、亚太地区、南美和中美以及中东和非洲。北美顺势疗法市场分析基于三个主要国家——美国、加拿大和墨西哥。据估计,美国顺势疗法市场在预测期内将占据最大的顺势疗法市场份额。随着消费者对顺势疗法的认识和兴趣不断提高,美国顺势疗法市场的增长得到了人们的关注。消费者正在积极寻求替代的医疗保健选择,并且更愿意探索顺势疗法,从而促进市场扩张。根据美国国家医学图书馆的数据,顺势疗法仅占美国人口的 2%,主要用于治疗呼吸系统、耳鼻喉科和肌肉骨骼疾病。在美国,去看顺势疗法提供者的消费者比没有去看顺势疗法提供者的消费者更有可能认为该疗法有帮助。大约只有 19% 的美国用户会去咨询顺势疗法医疗保健提供者。顺势疗法药物是矿物质、植物和生物物质的活性微剂量,可治疗各种急性健康状况,包括过敏、咳嗽、感冒、流感、肌肉疼痛和压力。美国流感负担的增加预计将在预测期内增加顺势疗法药物的采用。根据疾病控制和预防中心 (CDC) 的数据,2019-2020 年期间,估计有 3800 万人因流感而患病。此外,人们对长期使用对抗疗法药物副作用的认识不断提高,从而有助于顺势疗法市场的增长。顺势疗法药物已被美国食品药品监督管理局 (FDA) 作为药品进行监管,并严格按照美国顺势疗法药典 (HPUS) 和药品良好生产规范 (GMP) 进行生产。在加拿大,加拿大卫生部将顺势疗法产品归入天然健康产品类别进行监管。在加拿大,顺势疗法药物属于 NHP 的定义,并在《天然健康产品法规》中被特别提及。这些产品经过审查和评估,以验证其安全性和健康声明。顺势疗法药物的声明得到了教科书和顺势疗法实践中使用的其他参考资料的支持。为了在店内识别顺势疗法药物,加拿大卫生部提供了一个授权号。该产品有一个八位数字,前面有一个“DIN-HM”,表示顺势疗法产品。加拿大卫生部批准了 8,500 多种顺势疗法产品。根据加拿大卫生信息研究所的数据,2021 年,加拿大的总医疗支出预计将达到 38 万美元。总体而言,预计医疗支出占加拿大国内生产总值 (GDP) 的 12.8%。根据不列颠哥伦比亚大学的数据,预计支出增加将导致更多加拿大人选择预防性护理以及顺势疗法等补充和替代医学 (CAM) 疗法。预测期内,慢性病的日益流行可能会加速顺势疗法药物市场的增长。根据世界卫生组织发布的一项研究,2020 年加拿大估计诊断出 28,026 例新的乳腺癌病例。根据同一项研究,该国新诊断出近 29,972 例前列腺癌病例,占 2020 年诊断出的所有癌症病例的 10.9%。癌症病例的如此高增长正在推动该国的需求。顺势疗法药物在增强免疫力方面显示出对化疗后副作用的积极作用。

 

行业发展和未来机遇:

以下列出了全球顺势疗法市场的主要参与者采取的各种举措:

  • 2022 年 5 月,Hyland's Naturals 推出了一项新的品牌活动,包括新的标识、徽标、网站和全国媒体发布,反映了公司消费者健康产品组合的增长以及专注于维生素矿物质和补充剂类别的重新定义的战略。Hyland's Naturals 的新外观和感觉代表了对创新的承诺以及公司保持家庭健康的宗旨。
  • 2020 年 1 月,PEKANA NATURHEILMITTEL GmbH 与 ADELMAR PHARMA GmbH 联手生产顺势疗法药物。他们开发了全面的高效疗法系列,帮助医生成功治疗急性和慢性疾病,同时避免使用对抗疗法药物时经常出现的有害副作用。

 

Covid-19的影响: 

在疫情期间,人们将重点放在增强免疫系统上,因此对支持整体免疫健康的顺势疗法药物的需求也随之增加。与许多行业一样,顺势疗法市场也面临挑战,因为供应链中断可能会影响某些产品的供应。一些国家/地区允许临时监管灵活性,以确保在疫情期间顺势疗法药物的供应。因此,COVID-19 疫情导致对顺势疗法的需求增加,并在医疗保健环境中适当使用这些产品,从而在预测期内推动全球顺势疗法市场的发展。

 

顺势疗法市场报告范围

报告属性细节
2022 年市场规模60.2 亿美元
2030 年的市场规模180.7 亿美元
全球复合年增长率(2022 - 2030 年)14.7%
历史数据2020-2021
预测期2023-2030
涵盖的领域按来源
  • 植物
  • 动物
  • 矿物质
按类型
  • 稀释
  • 酊剂
  •  生化
  • 软膏
  • 平板电脑
  • 其他的
按应用
  • 镇痛解热
  • 呼吸系统
  • 神经病学
  • 免疫学
  • 胃肠病学
  • 皮肤科
  • 其他的
按分销渠道
  • 顺势疗法诊所
  • 零售药店
  • 电子零售商
  • 其他的
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  •  
  • 福尔茨
  • 艾伦医疗有限公司
  • 哈尼曼实验室有限公司
  • Boiron, Homeocan Inc
  • Hyland's 公司
  • 纳尔逊药房有限公司
  • Weleda 英国
  • 生物医用产品 Heel GmbH
  • 安斯沃思(伦敦)有限公司
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

竞争格局和重点公司:

全球顺势疗法市场的一些知名参与者包括 Fourrts、Allen Healthcare Co. Ltd;Hahnemann Laboratories, Inc;Boiron、Homeocan Inc;Hyland's, Inc.;Nelson Pharmacies Limited、Weleda UK、Biologische Heilmittel Heel GmbH;Ainsworths (London) Limited;DHU-Arzneimittel GmbH & Co. KG;Dr Reckeweg & Co GmbH、Similasan Corp;PEKANA Naturheilmittel GmbH 等。这些公司专注于各种增长战略,如合作、产品发布、业务扩展、协议等,以保持其在全球市场的地位。他们拥有广泛的全球影响力,可以为大量客户提供服务,从而增加其顺势疗法市场份额。

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is meant by the homeopathy market?

Homeopathy is an alternative form of medicine that uses highly diluted substances to stimulate the body’s natural healing abilities. Several factors contribute to the growth of homeopathy market. The prevalence of chronic diseases and lifestyle related health problems has been on the rise and homeopathy is often sought for managing chronic conditions and improving overall well-being. Increased awareness of homeopathy and its potential benefits, along with growing acceptance among healthcare professionals, have contributed to its wider adoption. Homeopathic products are primarily sourced from plants (such as red onion, arnica [mountain herb], poison ivy, belladonna [deadly nightshade], and stinging nettle), minerals (such as white arsenic), or animals (such as crushed whole bees). Homeopathic products are often made as sugar pellets to be placed under the tongue; they may also be in other forms, such as ointments, gels, drops, creams, and tablets. Treatments are “individualized” or can be customized as per the requirements from consumers.

Which segment led the homeopathy market?

Based on source type, the plants segment held the largest market share in 2022, and the same segment is anticipated to register the highest CAGR of 14.9% during the forecast period.

Which distribution channel segment held the largest revenue (US$ Mn) in the homeopathy market?

The homeopathic clinics segment held the largest share of the market in 2022 and the same segment is anticipated to register the highest CAGR of 15.2% in the market during the forecast period.

Who are the key players in the homeopathy market?

Fourrts, Allen Healthcare Co. Ltd; Hahnemann Laboratories, Inc; Boiron, Homeocan Inc; Hyland's, Inc.; Nelson Pharmacies Limited, Weleda UK, Biologische Heilmittel Heel GmbH; Ainsworths (London) Limited, DHU-Arzneimittel GmbH & Co. KG; Dr Reckeweg & Co GmbH, Similasan Corp; PEKANA Naturheilmittel GmbH; among others are among the leading companies operating in the homeopathy market.

What are the driving factors for the homeopathy market across the globe?

Factors such as safety associated with homeopathic products and rise in adoption of homeopathic medicine are the key drivers aiding the growth of the homeopathy market.

The List of Companies - Homeopathy Market

  1. Fourrts
  2. Allen Healthcare Co. Ltd
  3. Hahnemann Laboratories, Inc
  4. Boiron, Homeocan Inc
  5. Hyland's, Inc.
  6. Nelson Pharmacies Limited
  7. Weleda UK
  8. Biologische Heilmittel Heel GmbH
  9. Ainsworths (London) Limited
  10. DHU-Arzneimittel GmbH & Co. KG
  11. Dr Reckeweg & Co GmbH
  12. Similasan Corp
  13. PEKANA Naturheilmittel GmbH

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Pharmaceuticals : READ MORE..